Monday, December 1, 2025
HomeIndustriesHealthcare

Healthcare

Ligand’s Partner Travere Therapeutics Announces FDA Accelerated Approval of FILSPARI™ (sparsentan), the First and Only Non-immunosuppressive Therapy for the Reduction of Proteinuria in IgA...

Ligand Pharmaceuticals Incorporated announced that its partner Travere Therapeutics, Inc.  has received accelerated approval from the U.S. Food and Drug Administration for FILSPARI to...

Emory Healthcare Engages Linus Health on Initiative to Expand Early Detection of Alzheimer’s Disease and Other Dementias

Linus Health, a digital health company focused on transforming brain health, announced that the Goizueta Institute Emory Brain Health and The Seavey Clinic at...

PathAI Announces Two New Executives to Expand Regulatory Expertise and Precision Oncology Commercial Strategy

PathAI, a leading provider of AI-powered pathology tools to advance precision medicine,  announced that Nick Anderson, Ph.D, has joined as Vice President of Regulatory...

Surfacide Announces Expansion Of UV-C Disinfection Technology Across All MedStar Health Hospital Locations

Surfacide, the industry leader in UV-C disinfection technology, announced that it is expanding the use of Surfacide's best-in-class Helios low-level UV-C Disinfection System across...

Stimufend Now Available in the United States

Fresenius Kabi announced the immediate availability in the U.S. of Stimufend, the company’s biosimilar to Neulasta, for use in patients at risk for febrile...
0FansLike
0FollowersFollow
spot_img

Hot Topics